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Hand, Foot, and Mouth Disease in 
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Victor Hsiao1, Fengfeng Liu3, Yaming Zheng3, Zhaorui Chang3, Chen Yuan3, 
C. Jessica E. Metcalf1,6, Hongjie Yu3 & Bryan T. Grenfell1,7
Hand Foot and Mouth Disease (HFMD) constitutes a considerable burden for health care systems 
across China. Yet this burden displays important geographic heterogeneity that directly affects the 
local persistence and the dynamics of the disease, and thus the ability to control it through vaccination 
campaigns. Here, we use detailed geographic surveillance data and epidemic models to estimate the 
critical community size (CCS) of HFMD associated enterovirus serotypes CV-A16 and EV-A71 and we 
explore what spatial vaccination strategies may best reduce the burden of HFMD. We found CCS ranging 
from 336,979 (±225,866) to 722,372 (±150,562) with the lowest estimates associated with EV-A71 in 
the southern region of China where multiple transmission seasons have previously been identified. Our 
results suggest the existence of a regional immigration-recolonization dynamic driven by urban centers. 
If EV-A71 vaccines doses are limited, these would be optimally deployed in highly populated urban 
centers and in high-prevalence areas. If HFMD vaccines are included in China’s National Immunization 
Program in order to achieve high coverage rates (>85%), routine vaccination of newborns largely 
outperforms strategies in which the equivalent number of doses is equally divided between routine 
vaccination of newborns and pulse vaccination of the community at large.
Hand, Foot, and Mouth Disease (HFMD) was first identified in New Zealand in 19571, and subsequently has been 
reported across the Asia-Pacific region where it is now endemic. Over the last two decades, HFMD outbreaks have 
been reported in: Malaysia2, Taiwan, China3, Japan4, Singapore5, Vietnam6, Mainland China7,8, Hong Kong Special 
Administrative Region  China9, South Korea10, and Cambodia11. The disease is mainly caused by multiple sero-
types of the Enterovirus A species in the genus Enterovirus of the Picornaviridae family, and predominantly affects 
young children under the age of five. In most instances, the infected individuals exhibit mild and self-limiting 
infections that include fever and skin eruptions on the hands and feet, as well as mouth sores1. However, in a small 
proportion of cases (0.03%12)—the majority involving the serotype EV-A71—the infection can lead to serious neu-
rological complications that can be fatal2,13,14. Because of these potential complications, HFMD constitutes a con-
siderable burden for health care systems throughout Asia and also has non-negligible economic consequences15,16.
In China, which accounts for the majority of cases worldwide17, up to 11.8 million cases have been reported 
between 2008 and 2014. In reaction, the Chinese Center for Disease Control and Prevention initiated a sur-
veillance program to reference HFMD cases with an unprecedented level of geographic detail (province, pre-
fecture, county and township levels, respectively 1st, 2nd, 3rd, and 4th administrative divisions). Concomitantly, 
three manufacturers in China have been developing inactivated monovalent EV-A71 vaccines that were found 
to provide high protective efficacy (90.0–97.4%) against EV-A71 in infants and young children in phase III 
trials18,19. Currently one monovalent EV-A71 vaccine is in license approval process, and two monovalent vaccines 
were licensed in December 2015 by the Chinese Food and Drug Administration20. In this context, a quantitative 
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understanding of the spatio-temporal dynamics of HFMD in China could help to optimally deploy this new 
vaccine in light of the demographics and the economics of the country as well as the epidemiology of the disease 
(Wu et al.,21 in review).
Mathematical models have provided useful insights into the dynamics of similar self-immunizing childhood 
infections such as measles22–25, rubella26–28, or pertussis29–31. With regards to vaccination, models can be used to 
evaluate the impact of different vaccination strategies, and optimally allocate a limited number of vaccine doses 
across geographic areas28 and age groups32,33. Previous model-based analyses have explored the seasonal patterns 
of HFMD and attempted to estimate key epidemic indicators such as the basic and effective reproductive num-
bers34–37. Additionally, Takahashi et al.38, recently used a time series Susceptible-Infectious-Recovered (TSIR) 
model to evaluate the potential for competitive release of CV-A16 for a hypothetical nation-wide vaccination 
campaign against EV-A71. Another important epidemic parameter to characterize in the context of vaccination 
campaigns is the critical community size (CCS)—the size of an isolated population below which a pathogen can-
not persist without re-introduction39.
The CCS is a complex parameter that is specific to each disease and depends on the seasonality and the inten-
sity of transmission40,41, the pattern of arrival of infected individuals, as well as the recruitment of susceptible 
individuals, either through variations in birth rate or migration42. In a context of high vaccination uptake, the 
CCS can strongly influence the spatio-temporal dynamics and hence the persistence of childhood disease in the 
long term. As China displays important geographic gradients in population density and in transmission intensity 
of HFMD38, characterizing the CCS across regions could affect the efficiency of competing spatially heteroge-
neous control strategies, allowing, for example, for reduced focus in coverage on zones below the CCS43. To our 
knowledge, none of the previous modelling studies on HFMD have attempted to quantify the CCS of the disease. 
The unprecedented spatial resolution of the Chinese surveillance dataset opens new possibilities to investigate the 
dynamics of HFMD across a range of community sizes and quantify its potential for local persistence.
Objectives
In this study we use detailed geographic surveillance data to quantify the CCS of HFMD in China’s northern and 
southern regions using both observed and simulated incidence from TSIR epidemic models. Subsequently, we 
explore what spatial patterns of vaccination may best reduce the burden of HFMD in a context of limited vaccine 
availability.
Methods
Data. In this study, we used a four-year time series (2010–2013) of weekly incidence of clinically and labora-
tory confirmed cases of HFMD from the nationwide Notifiable Infectious Diseases Reporting Information System 
(NIDRIS) maintained by the Chinese Center for Disease Control and Prevention. These sparse time series data 
were available at the township level (4th administrative division of China) and were aggregated to the county level 
(3rd administrative division) and to the province or municipality level (1st administrative division) for consistency 
with Takahashi et al.38. Weekly incidence of HFMD was also available at the prefecture level but was not used as 
too few time series experienced interruptions that could be exploited to evaluate the CCS. To reconstruct the 
respective incidence of EV-A71 and CV-A16 associated HFMD in each province, we used the proportions of 
each of those serotypes amongst lab-confirmed cases (other serotypes were not considered in this study). This 
procedure is identical to Takahashi et al.38 using the data from NIDRIS. At the province level, there were moderate 
discrepancies between the aggregated incidence of CV-A16 and EV-A71 and the incidence from NIDRIS used by 
Xing et al.12 and Takahashi et al.38 (median provincial correlation = 0.65). At the county level, the incidence time 
series was reconstructed for each EV-A71 and CV-A16 using binomial sampling of all clinically confirmed HFMD 
cases, with a sampling probability equal to the proportion of cases associated with either EV-A71 or CA-A16 in the 
surrounding province. In this study all weekly incidence reports were pooled in years of 52 weeks for simplicity.
Estimation of critical community size (CCS). The CCS for EV-A71 and CV-A16 in China was estimated 
from the county-level incidence in the southern and northern epidemic regions of China (as defined in Xing et al.12). 
For each strain we use two approaches to estimate the CCS: first using the observed incidence (corrected for under-
reporting), and second using simulated incidence from TSIR simulations23,24,44 with immigration dynamics. CCS 
estimates from township-level incidence were not considered because in most locations, the time series were too 
sparse to apply the TSIR models. Underreporting rates were obtained for each province by estimating the weekly 












Where Bt is the weekly number of births, ρt is the reporting rate estimated using a smoothing spline with four 
degrees of freedom, ′It  is the observed incidence, and Dt represents the residuals of the fitted function at each time 
step (Appendix I). The numbers of births by province per week were derived from the yearly birth rates obtained 
from the National Bureau of Statistics of China. Because the reporting rates obtained were very low, we used a 
resampling procedure described in Appendix II that prevents underestimating of the tails of each epidemic wave 
when correcting the incidence for underreporting in small populations. Weekly births at the county level were 
calculated as the number of weekly births at the province level multiplied by the ratio between each county’s pop-
ulation and its corresponding province population.
CCS from reported incidence. The CCS values obtained from the observed incidence (corrected for underreport-
ing) were estimated using the relationship between the log10 of the population in each district and the proportion 
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of zeros in each incidence time series. For each epidemic region and strain, the intersection of the fitted smooth-
ing splines (df = 4, see Appendix IV for sensitivity analysis) with the population axis gives the estimate of the 
CCS29. The population estimate can be interpreted as the threshold population size below which the disease 
cannot sustain itself without repeated re-introduction
CCS from simulated incidence. Next we simulated the weekly incidence of EV-A71 and CV-A16 in each county 
using a time series SIR model. The dynamics of the susceptible and infectious individuals within each spatial unit 
are given by
= + −+ +S S B I (2)t t t t1 1
λ θ∼ ++ +I Pois ( ) (3)t t t1 1
λ β= ⋅ ⋅α+ I S N( )/ (4)t t t t t1
Here, St is the number of individuals that are susceptible, Bt is number of births, It is the number of infected indi-
viduals corrected for underreporting at time t, λ t+1 is the expected value of the number of individuals infected 
at time t + 1, θ t is the number of infected individuals immigrating in the spatial unit, β t, is a seasonally-varying 
transmission rate, α is a correction parameter accounting for non-seasonal heterogeneities in mixing as well as 
for time discretization23,44, and Nt is the total population size in the spatial unit. The transmission rates β t, and the 
number of migrants θ t were fitted independently in each spatial unit (Eqs 6 and 7) whilst α was spatially invari-
ant. For consistency with previous modelling works on childhood infections, we assumed frequency-dependent 
transmission, a choice motivated by the fact that for such childhood infections the social clique size is relatively 
constant23,45,46.
In this study we used the TSIR framework in a two-step procedure: For the first step, we fitted the model at the 
province level, omitting the immigration term, θ , as its influence on the dynamics is negligible in the very large 
populations that make up entire Chinese provinces. This allows us to estimate the seasonally varying transmission 
rates βt by taking the log transformation of Eq. 4:
λ β α= + ⋅ + −+log log log I log S log N( ) ( ) ( ) ( ) ( ) (5)t t t t t1
where α is fixed to 0.9538, and St can be expressed as = ⋅ +S N D( s )t t tMean  with Dt estimated as the residuals of 
the fitted smoothing spline of the cumulative number of births on the cumulative number of cases (Eq. 1). The 
proportion of susceptible individuals sMean for each province was taken from Takahashi et al.38.
In the second step, we use Eqs 2 and 3 to simulate the dynamics in each of the 2,897 counties that reported 
HFMD cases and we apply the following scaling factors ϕ β, and ϕ θ, with values specific to each individual county, 
on the provincial transmission rate βt and the immigration term θ t, such as,
β = ϕ ⋅ ββ (6)t ,County Province
and
θ ∼ ϕ ⋅ ⋅θPois ( N I ) (7)tCounty County ,Province
where NCounty and It,Province are respectively the number of individuals in the county and the incidence in the prov-
ince containing the county (Fig. 1). For each county, we ran a constrained minimization procedure with 500 sim-
ulations varying the scaling factors within a range of plausible values, φ θ = [0, 1] and φ β = [0, 10] (varying evenly 
across the corresponding range), the latter to enable the model to capture potential variation in the intensity of 
the frequency-dependent transmission (Fig. 1).
The best set of scaling factors was identified by comparing four years of simulated incidence to the observed 
incidence (corrected for underreporting) using the square mean root error as the fitting metric. Simulations were 
run for 40 years to bring the system to its dynamic equilibrium, before comparison with the observed incidence 
time series.
Additionally, a conditional threshold of one weekly migrant was imposed during the minimization procedure 
in order to avoid biased values (overestimates) for φβˆ  as a compensation mechanism for premature stochastic 
extinction in small counties. Using this condition for the minimization procedure did not substantially affect the 
within-county dynamics (Appendix V), as the number of infected migrants remained on average one order of 
magnitude lower than the observed incidence in the counties with the lowest HFMD presence (25% of total coun-
ties). When running simulations to estimate the CCS and test vaccination strategies this condition was relaxed in 
order to enable the extinction-recolonization dynamics. Finally, the simulated incidence obtained through this 
two-step procedure was used to calculate the CCS following the same methodology as described for the observed 
incidence time series (Fig. 2 for EV-A71 and Fig. 3 for CV-A16). Finally, the differences (or lack thereof) CCS 
obtained for each region, and incidence time series (observed vs predicted) was assessed using a three step proce-
dure: fist we used the jackknife residuals of the fitted smooth spline to calculate the 95% CI around the intersec-
tion of the spline with the population axis. Second, based on this interval, we constructed normal distributions of 
the probable CCS value with a number of samples equal to the number counties used to estimate to CCS in each 
region. Third we used a two-sided t-tests on these distributions to assess the difference in CCS between the two 
regions. Two-sided t-tests weighted by the number of counties used for the estimation (Figs 2 and 3).
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Vaccination Strategies. In each county, simulations of vaccination were run using the scaling factors φβˆ , 
and φθˆ , identified from the optimization procedure, as well as the initial number of infectious and susceptible 
individuals on the first week of the 39th year of simulation. Epidemics were run for 20 additional years before 
vaccination started.
First, we studied the impact of routine vaccination of newborns with increasing coverage rate p on the CCS of 
HFMD in each epidemic region of China (Fig. 4).
Second, we considered the eventual targeting of a limited number of vaccines to newborns in ‘priority areas’, 
thus implementing spatially heterogeneous vaccination strategies. The outcome of each strategy is measured by 
the decrease in the cumulated number of cases 5 years and 20 years following vaccination. In this instance, for 
each week, a number of doses equal to half the number of births per week in 2013, (n = 101,596 individuals) was 
distributed across the country according to five spatial strategies: A) Vaccination targeted in counties with the 
lowest population (n = 1,601 locations), B) vaccination in counties with the highest population (n = 678 loca-
tions), C) vaccination targeted in the counties which population is the closest to the regional CCS (n = 1,155 
locations), D) vaccination in randomly selected counties (n = 1,217 locations), and E) vaccination in counties 
with the highest average incidence (n = 1,669).
Third, we considered a case in which newborns across the entire country are vaccinated routinely with a cov-
erage rate of 85%, in every county (strategy F). This value was chosen to reflect the typical coverage for vaccines 
included in China’s National Immunization Program. We compared this strategy with the five spatially explicit 
vaccination strategies: the total number of doses used for strategy F was targeted to specific counties according to 
a spatial strategy, A, B, C, D, or E. In each county selected for vaccination, 85% of newborn were vaccinated and, 
in addition, an equal number of doses was administered through a single pulse vaccination of susceptible individ-
uals on the 6th week of the year (which corresponds to the minimum of the yearly incidence). Thus for strategies 
A, B, C, D and E, 42.5% of newborn in the whole country received routine vaccination. But vaccination at birth 
only occurs in selected counties (with coverage 85%) and is complemented by pulse vaccination. In the counties 
selected for vaccination, Eq. 2 can be extended for each year as follows,
= − ⋅ ⋅ + ⋅ − −+ = +S S p B B p I(52 ) (1 ) (8)t t t t t t1 6 1
where the weekly number of birth Bt is shrunk by a factor (1-p) with p corresponding to the vaccination coverage 
at birth adjusted for vaccine efficacy (94.80%)19 and (52· p·Bt|t=6) corresponds to the number of vaccine doses 
Figure 1. Scaling of the transmission parameters for the TSIR model between the province and county 
scale in Beijing municipality. (A) Guangdong Province (B) and Hubei Province (C). In each location the 
average transmission rate βt  was respectively scaled by a factor of 1.10, 2.42 and 0.05 for A, B and C after re-
fitting. This figure was generated using the open source statistical software R (cran.r-project.org), version 
number 3.0.3, including packages maptools and foreign.
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administered through pulse vaccination on the 6th week of a given year, once a year. Finally, for routine vaccina-
tion of newborns, we also considered coverage rates reflecting differences in socio-economic status across prov-
inces (strategy F*), see Appendix III). The provincial coverage rates were derived for three childhood vaccines 
(Haemophilus influenza type B vaccine, rotavirus vaccine and Varicella vaccine). These were obtained through a 
literature review and stratified across three socio-economic groups (high-, middle-, and low-income provinces). 
Each province was assigned a minimum, mean and maximum coverage rate based on the literature available in its 
corresponding socio-economic group. Because these vaccines and the current candidate vaccine against EV-A71 
are not currently part of the National Immunization Program of China’s Ministry of Health, the uptake in each 
province may be influenced by local economic conditions47. All simulations of vaccination were replicated 250 
times to compute confidence intervals through Monte Carlo simulations for the reduction of incidence after 5 and 
20 years. The differences (or lack thereof) in the reduction of the number of infected individuals associated with 
each vaccination strategy was assed using an analysis of variance followed by multiple comparison test (Tukey).
Results
Model Fitting. For EV-A71, the median correlation coefficient and median R2 between observed and simu-
lated incidence at the provincial level were respectively 0.88 and 0.78 (Table 1). For CV-A16, the median correla-
tion coefficient and median R2 between observed and simulated incidence at the provincial level were respectively 
0.90 and 0.81 (Table 2). A scaled TSIR model including the extinction-recolonization dynamics could be fitted 
in 2,897 counties. The incidence weighed correlation coefficient was 0.47, and the R2 was 0.27 for EV-A71 and 
0.49 and 0.30 for CV-A16. The median reporting rates were very low, 4.20% for EV-A71 (Table 1) and 2.90% for 
Figure 2. Critical Community size of EV-A71. Population per county as a function of the proportion of zeros 
in weekly incidence for observed and predicted time series. The intersection of the fitted function with the 
y-axis indicated the estimate of the critical community size for EV-A71. N is the number of counties with at least 
one epidemic fadeout.
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CV-A16 (Table 2) respectively. The average transmission rates were consistent with the estimates of Takahashi 
et al.38 using data from NIDRIS.
Critical Community Size. For EV-A71 (Fig. 2), in the northern region the CCS was 722,372 (± 150,562 
C.I. 95%) for the estimate obtained from the observed time series and 390,850 (± 189,744 C.I. 95%) for the esti-
mate obtained from the simulated time series. Whilst in the southern region, the estimates for the CCS were 
525,104 (± 279,791 C.I. 95%) for the estimates obtained from the observed time series and 336,979 (± 225,866 
C.I. 95%) for the estimate obtained from the simulated time series. For CA-61 (Fig. 3), in the northern region 
the CCS was 679,249 (± 190,549 C.I. 95%) for the estimate obtained from the observed time series and 332,983 
(± 213,456 C.I. 95%) for the estimate obtained from the simulated time series. In the southern region, the esti-
mates for the CCS were respectively 554,268 (± 266,154 C.I. 95%) and 315,768 (± 249,074 C.I. 95%) for the esti-
mates obtained from the observed and simulated time series. We thus find comparable measures of CCS for 
CV-A16 and EV-A71. Significant differences in CCS were identified between regions (North versus South) when 
considering the observed incidence time series (p-value = < 0.001 for both CV-A16 and EVA-71) but not when 
considering the simulated incidence for CV-A16 (p-value = 0.35). When considering the simulated incidence for 
EVA-71, a significant difference was identified between the northern and the southern region (p-value < 0.001) 
but its magnitude was limited compared with the difference in CCS obtained from comparing the observed inci-
dence time series. Additional evidence for stronger persistence of EV-A71 in the southern region comes from the 
higher proportion of counties without a single epidemic fadeout in the southern region compared to the northern 
region. The southern region had an observed 21% and a predicted 62% of counties with no epidemic fadeout, 
Figure 3. Critical community size of CV-A16. Population per county as a function of the proportion of zeros 
in weekly incidence for observed and predicted time series. The intersection the fitted function with the y-axis 
indicated the estimate of the critical community size for CV-A16. N is the number of counties with at least one 
epidemic fadeout.
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Figure 4. Routine vaccination. Effect of routine vaccination at birth on the critical community size of HFMD 
in the Northern (blue) and Southern (red) regions of China.
Province Corr. R2 βt s
Rep. 
Rate
Beijing 0.792 0.628 42.74 0.035 0.0995
Tianjin 0.925 0.856 6.41 0.232 0.0897
Hebei 0.954 0.91 37.87 0.043 0.0391
Shanxi 0.969 0.939 35.58 0.044 0.0338
Inner Mongolia 0.926 0.857 2.09 0.738 0.03
Liaoning 0.875 0.766 35.25 0.043 0.0607
Jilin 0.932 0.868 5.71 0.262 0.0432
Heilongjiang 0.946 0.894 15.11 0.101 0.0186
Shanghai 0.864 0.746 22.8 0.067 0.0914
Jiangsu 0.907 0.823 30.12 0.054 0.0633
Zhejiang 0.881 0.776 43.16 0.037 0.0973
Anhui 0.868 0.754 36.99 0.044 0.0559
Fujian 0.887 0.786 52.61 0.03 0.0743
Jiangxi 0.816 0.666 20.16 0.08 0.0282
Shandong 0.975 0.95 5.31 0.308 0.0418
Henan 0.937 0.878 8.29 0.2 0.0296
Hubei 0.935 0.875 12.23 0.132 0.0544
Hunan 0.847 0.718 26.14 0.063 0.0657
Guangdong 0.863 0.746 19.65 0.084 0.1144
Guangxi 0.853 0.728 21.28 0.076 0.125
Hainan 0.723 0.523 11.32 0.131 0.1594
Chongqing 0.856 0.732 104.05 0.015 0.0355
Sichuan 0.799 0.639 96.06 0.017 0.0269
Guizhou 0.834 0.695 28.37 0.056 0.0405
Yunnan 0.886 0.785 47.14 0.034 0.0401
Tibet 0.617 0.38 30.61 0.049 0.0118
Shaanxi 0.932 0.869 55.65 0.028 0.0641
Gansu 0.97 0.941 20.41 0.076 0.0153
Qinghai 0.617 0.38 8.26 0.187 0.0111
Ningxia 0.972 0.945 1.47 1 0.0373
Xinjiang 0.965 0.932 4.7 0.331 0.0092
Table 1. EV71. Provincial TSIR, fitting correlation coefficient, coefficient of determination, mean transmission 
rate and mean proportion of susceptible.
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while the northern region had less than 1% observed and 14% of predicted counties with no epidemic fadeout 
between 2010 and 2013.
Vaccination Strategies. Simulations of routine vaccination of newborns across China suggest that the CCS 
would significantly increase at high coverage rates (Fig. 4A). At a vaccination rate of 85%–as expected if the 
vaccine is included in the NIP– the benefits of routine vaccination would be comparable in the northern and 
southern regions with increases in CCS of 130% (from 390,850 to 900,750) and 125% (from 336,979 to 758,332) 
respectively. Further increasing vaccination rates (> 90%) to raise the CCS would marginally benefit the Northern 
region relative to the Southern region (Fig. 4B), this is that any increment of 1% in vaccination coverage yields to a 
higher increase in CCS in the northern region compared to the Southern region. However these estimates should 
be treated with caution; at high vaccinations rates (95–99%) there are only a few dozen counties experiencing 
discontinued epidemics that could be used in further simulations to estimate the CCS.
Five spatial vaccination strategies were simulated at the county level (Fig. 5, Tables 3 and 4). For Strategy A, 
large rural counties in the western region of China, Sichuan and Heilongjiang provinces as well as the peri-urban 
counties of the South East were selected for vaccination. All major agglomerations were excluded. For Strategy 
B areas subject to vaccination are located in major urban center such as the south of Guangdong province, the 
municipalities of Shanghai and Beijing, as well as the surroundings of Chongqing, Chengdu and Hunan prov-
inces. For strategy C most peri-urban areas in the country were selected for vaccination, but all the very rural or 
highly populated counties located on the South-East coast were excluded. For strategy E most urban centers were 
selected for vaccination with additional counties in the northern and western region.
In a context where the number of doses available is equal to half the number of yearly births (Table 3), the 
strategy consisting in targeting vaccination in areas of highest prevalence (E) or the largest population (C) showed 
the largest reduction in the cumulative number of infectious individuals over a period of 5-years (E = 48.8%, 
C = 46.7%) and 20-years (E = 53.8%,C = 49.5%). Compared with strategies A, B and D, strategy (E) was 37.8% 
(A), 32.2% (B) and 35.1% (D) more efficient for reducing incidence five years after vaccination, and (A) 26.8% , 
(B) 23.1%, and (D) 24.2% 20-years after vaccination (Appendix VI).
Province Corr. R2 βt s Rep.Rate
Beijing 0.907 0.823 50.08 0.03 0.0658
Tianjin 0.799 0.639 29.17 0.051 0.06176
Hebei 0.959 0.92 28.63 0.057 0.02432
Shanxi 0.925 0.856 35.63 0.044 0.02349
Inner Mongolia 0.937 0.878 25.28 0.061 0.02536
Liaoning 0.959 0.92 33.73 0.045 0.03746
Jilin 0.937 0.878 31.11 0.048 0.02974
Heilongjiang 0.516 0.266 66.61 0.023 0.01076
Shanghai 0.85 0.722 37.21 0.041 0.07835
Jiangsu 0.928 0.862 30.68 0.053 0.03842
Zhejiang 0.878 0.771 24.2 0.066 0.05809
Anhui 0.86 0.74 23.62 0.069 0.03612
Fujian 0.892 0.796 21.36 0.074 0.04757
Jiangxi 0.827 0.684 17.02 0.095 0.01899
Shandong 0.977 0.954 11.93 0.137 0.0273
Henan 0.934 0.872 36.02 0.046 0.01834
Hubei 0.917 0.84 29.91 0.054 0.03221
Hunan 0.872 0.76 29.91 0.055 0.04104
Guangdong 0.842 0.708 56.93 0.029 0.07558
Guangxi 0.857 0.734 40.41 0.04 0.08797
Hainan 0.712 0.507 21.83 0.068 0.08981
Chongqing 0.87 0.757 16.91 0.093 0.02302
Sichuan 0.812 0.66 29.24 0.056 0.01494
Guizhou 0.805 0.648 26.06 0.061 0.02541
Yunnan 0.88 0.775 23.24 0.069 0.02726
Tibet 0.458 0.21 11.15 0.143 0.00595
Shaanxi 0.963 0.927 41.23 0.038 0.03663
Gansu 0.949 0.9 34.35 0.045 0.00997
Qinghai 0.845 0.715 5.22 0.296 0.03849
Ningxia 0.946 0.894 10.32 0.143 0.02454
Xinjiang 0.935 0.873 28.09 0.056 0.00502
Table 2.  CA16 Provincial. TSIR fitting correlation coefficient, coefficient of determination, mean transmission 
rate and mean proportion of susceptible.
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In a context where the number of doses available is sufficient to achieve 85% coverage of newborns, this vac-
cination strategy (F) outperforms all the spatially explicit strategies based on a combination of newborn vaccina-
tion and pulse vaccination using the same number of doses across the country (A–E). The routine vaccination of 
newborns at coverage rates reflecting the level of coverage achievable under the national immunization program 
could result in a reduction in the number of infectious individuals of 71.7% after 5 years and 77.8% after 20 years 
(Table 4). The relative reduction in the number of infected individuals after 5 years for routine vaccination was 
92% to 47% more important compared with all the spatially targeted strategies combining routine birth vaccina-
tion with pulse vaccination. Finally, the routine vaccination of newborns with coverage rates reflecting vaccine 
uptake for other similar childhood diseases that are not currently included in the NIP (strategy F*) showed a low 
reduction in the number of infectious individuals (40% after five years) compared to the reduction that could be 
achieved under the NIP (> 85% coverage).
Discussion
Critical Community Size. In this study we used incidence time series and mathematical models to estimate 
the CCS of HFMD in China, and investigate the effect of spatially heterogeneous vaccination strategies against 
EV-A71. To our knowledge this study is the first to attempt to quantify the CCS of HFMD in China. Our results 
suggest a comparable CCS for CV-A16 and EV-A71 but significant differences between regions (North versus 
South). The magnitude of these regional differences, and in particular the smaller critical community sizes iden-
tified in the southern region are consistent with the longer seasonal persistence reported by Xing et al.12 as well 
as and the bi-annual transmission dynamics identified by Takahashi et al.38. Longer transmission seasons in the 
South potentially allows the disease to persist in smaller communities by increasing chances of re-introduction, 
and this may be a critical feature to consider when implementing nation-wide vaccination campaigns. In this 
context, we identified that routine vaccination of newborns could substantially increase the population threshold 
for persistence of HFMD. The benefits of routine vaccination would be more pronounced in the northern region 
Figure 5. Spatial vaccination strategies. (A) Vaccination targeted in counties with the lowest population,  
(B) vaccination in the highly populated counties, (C) Vaccination in the counties where population is the close 
to the regional CCS, and (D) vaccination in randomly selected counties. (E) Vaccination in high prevalence 
counties. Red indicates vaccinated areas, white indicates unvaccinated areas, grey indicates areas excluded from 
the analysis. This figure was generated using the open source statistical software R (cran.r-project.org), version 






Random (A) 35.4 [33.1;37.7] 42.4 [41.9;42.8]
Close-CCS (B) 36.9 [34.2;39.6] 43.7 [43.3;44.2]
Large(C) 46.7 [44.2;49.2] 49.5 [49.0;50.1]
Small(D) 36.1 [33.7;38.5] 43.3 [42.8;43.7]
High Prevalence (E) 48.8 [46.7;50.9] 53.8 [53.4;54.2]
Table 3. Mean reduction in the cumulated number of infectious individuals following weekly vaccination 
of 50% of newborns according to different spatial vaccination strategies. Coverage rate = 85% and vaccine 
efficacy = 94.8% in each vaccinated county.
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at moderate vaccination rates. Overall, we found considerable evidence for local persistence of both serotypes of 
HFMD, in particular in the southern region.
For each strain, EV-A71 and CV-A16, we found important discrepancies between CCS estimates obtained 
through simulation versus reported incidence, with ratios ranging from 2.03:1 to 1.56:1 depending on the sero-
types and region considered. The smaller regional differences for the CCS obtained from the simulated incidence 
may further be attributed to this procedure because by indistinctively filling interruptions in times series the 
process may generate similar epidemic patterns from small outbreaks. CCS estimates obtained from the reported 
cases might at first be considered more reliable, as they are directly derived from only epidemiological evidence. 
However, we show that the reporting rates of HFMD are likely very low in agreement with previous evidence 
for underreporting38. The proportion of zeros in the incidence time series may thus be largely overestimated 
and consequently lead to overestimates of CCS28. Whilst our approach for correcting underreported time series 
partly attempts to address this issue (Appendix II), the adjusted incidence should nonetheless be treated with 
caution. As a consequence of the very low reporting rates, prolonged interruptions in reported incidence may 
correspond to either an actual interruption in transmission or no cases being reported. In the absence of detailed 
epidemiological studies on treatment-seeking behavior as well as a better quantification of potentially time var-
ying reporting rates these two situations cannot be distinguished. In this context CCS estimates obtained from 
simulated incidence provide a methodological alternative to the correction of observed incidence with very low 
and therefore uncertain reporting rates. Additionally, the smaller regional differences for the CCS obtained from 
the simulated incidence may further be attributed the underreporting procedure and the migration terms as 
implemented in the TSIR model, because by indistinctively filling interruptions in times series the process may 
generate similar epidemic patterns for different areas characterized by regular small outbreaks. Whilst the accu-
racy of the estimates obtained through simulation is contingent on the parameterization of the immigration 
process as well as the mathematical structure of our epidemic model, we found that our estimates of CCS are 
not dissimilar from other (and more extensively studied) self-immunizing childhood illnesses such as measles , 
rubella and pertussis29.
Spatial Vaccination Strategies. We simulated seven vaccination strategies, including five strategies to 
target a limited number of doses to specific geographic areas characterized by either high, low, medium and 
randomly selected population sizes or high prevalence of HFMD. The underlying and competing hypothesis 
as to why each vaccination strategy implemented could yield to the best results in term of reducing the number 
of HFMD cases goes as follows. On one hand, targeting vaccination primarily in highly populated (or highly 
infected) counties could decrease the intensity of the recolonization mechanism even if the level of vaccination is 
insufficient to locally eradicate the disease. This is possible because highly populated (or highly infected) counties 
contribute an important share to the provincial incidence which directly affects the intensity of the recolonization 
process as formulated in our model. This strategy could be seen as ‘turning off the tap’ of infections from large 
areas that might subsequently spillover into the smaller areas. On the other hand, the alternative hypothesis which 
consists of targeting vaccination primarily in many small populations is related to the idea that if the small popu-
lations are brought under a critical threshold, the probability of stochastic extinction at the scale of small popula-
tions increases substantially, and thus epidemics will progressively fade out as the result of susceptible depletion. 
An analogy for this strategy could be seen as ‘putting out a large fire with a blanket’, working from the edge to limit 
the oxygen uptake and progressing towards the center of the fire. In this study, we observe that the ‘turning off the 
tap’ strategies—targeting vaccination in high prevalence areas or large populations—outperforms the other strat-
egies implemented. Vaccination targeted in populations close to the CCS does not have a strong advantage over 
vaccination in small areas43. Thus if vaccination campaigns against HFMD should be implemented in the foresee-
able future, and if the number of doses is limited, our results suggest these resources would be optimally deployed 
in highly populated urban areas and in high prevalence areas which is potentially also easier to implement from 
a logistical standpoint. If the number of doses is sufficient to cover all new births, our results suggest that routine 
vaccination at birth would be the most effective allocation of vaccines provided that the vaccine is included in 






Random (A) 46.1 [44.0;48.2] 48.1 [47.7;48.5]
Close-CCS (B) 38.2 [35.7;40.7] 43.3 [42.8;43.8]
Large(C) 47.7 [45.1;50.2] 49.2 [45.5;52.9]
Small(D) 37.3 [35.2;39.5] 42.4 [42.0;42.9]
High Prevalence (E) 48.6 [46.3;50.8] 52.4 [52.0;52.9]
Routine 85% (F) 71.7 [70.0;73.4] 77.8 [77.3;78.2]
Routine non-NIP (F*) 39.4 [23.3;56.6] 40.7 [25.2;60.0]
Table 4.  Reduction in the cumulated number of infectious individuals following vaccination of 85% 
newborns at birth (strategy F) or combination of routine vaccination (42.5%) and pulse vaccination 
(42.5%) according to different spatial vaccination strategies (A, B, C, D, E). Coverage rate = 85% and vaccine 
efficacy = 94.8% in each vaccinated county. *The confidence interval for simulations of vaccination outside of 
China’s National Immunization Program (non-NIP) are based on the range of estimates found from the existing 
literature (Supplementary Information, Table SIV 1).
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combination of pulse vaccination and birth vaccination were largely outperformed by routine vaccination with 
an equal number of doses by a large margin.
Limitations. As with any model-based study, our analysis is subject to assumptions and limitations. The TSIR 
framework used in this study does not presently account for age structure, cross-protection between HFMD 
serotypes or waning of vaccine-induced immunity (Hsiao et al., in prep45,). Our estimates for the reduction in the 
number of cases after 5 and 20 years may thus represent a conservative overestimate of the time necessary to reach 
the low levels of incidence presented in this study. Additionally the models used here were parameterized using 
the last four years of the time series of HFMD incidence. This choice was motivated by the unreliable reporting 
of HFMD in 2008–2009 that resulted in poor statistical fits at the province level if reports prior to 2010 were 
included. Using a 4-year time series here is necessarily short compared to other studies using the TSIR frame-
work, and this may thus affect the robustness of our simulations. Additionally, in order to fit epidemics parame-
ters in each county we used a scaling methodology that involves a baseline immigration of one migrant per week. 
Whilst this has limited effect on the overall dynamics of HFMD within each spatial unit (Supplementary Fig. S4) 
it may have marginally affected our final estimates of CCS. Finally, as surveillance has improved over the last 
decade, more recent incidence reports may be associated with higher reporting rates48, although yearly variation 
is partially captured through the use of a time-varying function such as the smooth spline used in the study.
Conclusion and next steps. Over the last couple of decades seasonal HFMD epidemics occurred regularly 
in East and South East Asian countries. Over the course of this period, urban migrations and urban population 
in these regions have increased in an unprecedented way (World Bank 2015). Symptomatic of this trend is the 
fact that 4 of the world’s 10 largest cities in 201549 were located in China. In this study, we highlighted the impact 
of such densely populated areas on disease dynamics: first these densely populated areas allow a disease such as 
HFMD to persist over large geographic areas despite its relatively high CCS, and second these areas play a key 
role in sustaining the immigration-recolonization dynamics in less densely populated peri-urban areas. Further 
work on the timing, seasonality and synchrony of epidemics along an urbanization gradient could help better 
understand the spatio-temporal dynamics of HFMD as well as other emerging childhood diseases in Asia. In this 
context, data on urbanization and within-China population movements could help to shed light on the mecha-
nistic process underlying the apparent dynamics of numerous childhood diseases.
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